Health & Safety Industry Today
India Genomics Market Valued at USD 2332.68 Billion in 2024, Forecast to Hit USD 8607.2 Billion by 2035 at a CAGR of 12.6%
India Genomics Market: Driving Precision Medicine and Biotechnology Innovation
The India Genomics Market is evolving rapidly, fueled by advances in sequencing technologies, growing government support for genetic research, and rising adoption of precision medicine across healthcare and biotechnology sectors. Genomics—the study of an organism’s entire genetic makeup—is revolutionizing healthcare by enabling personalized treatment, early disease detection, and innovative drug development. India’s growing focus on healthcare digitization, coupled with increased awareness of genetic testing and its clinical benefits, has made genomics one of the most promising segments of the life sciences industry.
As per MRFR analysis, the India genomics market Size was estimated at 2332.68 USD Million in 2024. The India genomics market is projected to grow from 2626.6 USD Million in 2025 to 8607.2 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 12.6% during the forecast period 2025 - 2035.
With an expanding population and a high burden of chronic diseases such as cancer, diabetes, and cardiovascular disorders, the demand for genomic solutions is surging across diagnostics, pharmaceuticals, and agriculture. The integration of artificial intelligence (AI), bioinformatics, and next-generation sequencing (NGS) technologies is further enhancing genomic data analysis and precision-based medical decision-making.
🔥 Request Your Sample Copy of This Strategic Report Now to Unlock Exclusive Market Insights and Forecast Data!
https://www.marketresearchfuture.com/sample_request/52467
Key Market Players
The India Genomics Market features strong participation from global biotechnology leaders and regional firms focused on advancing genetic research and sequencing capabilities. Key players driving innovation include:
- Illumina (US)
- Thermo Fisher Scientific (US)
- Roche (CH)
- Agilent Technologies (US)
- BGI Genomics (CN)
- Qiagen (DE)
- PerkinElmer (US)
- Eurofins Scientific (LU)
These companies are focusing on strategic collaborations, R&D investments, and technology transfers to enhance genomic testing infrastructure across India. Partnerships with hospitals, research institutes, and diagnostic centers are enabling wider accessibility to genetic testing and molecular diagnostics.
Market Segmentation Analysis
The India Genomics Market can be broadly segmented based on Application, Technology, and End Use, reflecting its diverse use across clinical, research, and industrial domains.
- By Application: The market includes diagnostics, drug discovery and development, personalized medicine, agriculture and animal research, and others. Diagnostic genomics holds a leading share due to the growing adoption of genetic screening for cancer, rare diseases, and hereditary conditions. Personalized medicine applications are expanding rapidly as healthcare providers move toward individualized treatment plans based on a patient’s genetic profile.
- By Technology: Key technologies in the market include polymerase chain reaction (PCR), microarray, sequencing, nucleic acid extraction and purification, and bioinformatics. Among these, sequencing technologies—especially next-generation sequencing (NGS)—dominate the market owing to their high throughput, speed, and accuracy. Continuous cost reduction and increased availability of sequencing platforms are boosting their adoption across both clinical and research settings.
- By End Use: The end-use segments include hospitals and clinics, diagnostic laboratories, pharmaceutical and biotechnology companies, and academic & research institutions. Hospitals and diagnostic labs lead the segment, driven by growing use of genetic testing for disease prevention, diagnosis, and treatment optimization. Meanwhile, pharmaceutical firms increasingly rely on genomic data for targeted drug discovery and biomarker identification.
💡 Purchase the Full Report for In-Depth Market Forecast and Strategic Business Insights!
https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=52467
Market Dynamics and Growth Outlook
The India Genomics Market is experiencing strong momentum due to several key growth drivers. The rise of government-led initiatives, such as the Genome India Project, aims to map genetic diversity and enhance the nation’s precision medicine capabilities. Increasing investments in biotechnology parks, research funding, and healthcare innovation hubs are further strengthening the genomic ecosystem.
Private sector participation is also accelerating, with diagnostic startups offering direct-to-consumer genetic testing for ancestry, wellness, and disease risk assessment. The falling cost of sequencing and data storage is making genomic testing more affordable and accessible to the Indian population.
Moreover, collaborations between academic institutions and genomic technology companies are leading to breakthroughs in rare disease research and gene therapy. The combination of AI and machine learning in genomics is improving data interpretation and enabling faster insights into genetic variations and their impact on health.
Regional Insights
Across India, genomics adoption is strongest in major metropolitan regions such as Bengaluru, Hyderabad, Pune, and Delhi NCR—centers known for their advanced biotechnology research and healthcare infrastructure. The presence of key research institutes, academic collaborations, and biotechnology clusters in these regions is fostering innovation and knowledge exchange.
Additionally, the expansion of diagnostic networks and government efforts to promote genomic literacy are enhancing accessibility in Tier 2 and Tier 3 cities. The growing number of clinical trials and research collaborations between Indian and global organizations is also contributing to market development.
Browse In-depth Market Research Report (Pages, Charts, Tables, Figures) : https://www.marketresearchfuture.com/reports/india-genomics-market-52467
Key Highlights
- Rising adoption of precision medicine and genetic testing in clinical diagnostics.
- Government initiatives like Genome India Project driving genetic data infrastructure.
- Growing partnerships between biotechnology companies and research organizations.
- Rapid advancements in next-generation sequencing (NGS) and bioinformatics.
- Expanding use of genomics in drug discovery, agriculture, and disease prevention.
- Increased affordability and awareness of direct-to-consumer genetic testing.
➤➤Explore MRFR’s Related Ongoing Coverage In Healthcare Domain:
Skin Antiseptic Product Market
Contract Manufacturers Of Medical Devices
Medical Device Contract Manufacturing
Healthcare Contract Manufacturing Market
Artificial Insemination Market
Cosmetic Surgery and Services Market
Cranial Fixation and Stabilization System Market
Cranio-Maxillofacial Fixation Device Market
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Share on Social Media
Other Industry News
Ready to start publishing
Sign Up today!
